NDC 63323-130-41 - DOXY 100(TM) DOXYCYCLINE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 63323-130
Requested NDC: 63323-130-41
Package NDCs from labels: 63323-130-03, 63323-130-13, 63323-130-41, 63323-130-17, 63323-130-02, 63323-130-11
Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Effective date: 2024-01-30
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
DOXY 100(TM) DOXYCYCLINE - HF Acquisition Co LLC, DBA HealthFirst	HF Acquisition Co LLC, DBA HealthFirst	2024-01-30	HUMAN PRESCRIPTION DRUG LABEL
Doxy 100 - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2021-02-17	HUMAN PRESCRIPTION DRUG LABEL
Doxy 100 - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2021-02-02	HUMAN PRESCRIPTION DRUG LABEL
Doxy 100 - Fresenius Kabi USA, LLC	Fresenius Kabi USA, LLC	2020-06-04	HUMAN PRESCRIPTION DRUG LABEL
Doxy 100 - General Injectables & Vaccines, Inc	General Injectables & Vaccines, Inc	2020-02-21	HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63323-130-02	Doxy 100	10 mL in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	10	8
63323-130-11	Doxy 100	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	8
63323-130-03	Doxy 100	10 mL in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	10	5
63323-130-13	Doxy 100	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	5
63323-130-17	Doxy 100	10 in 1 TRAY	INJECTION, POWDER, LYOPHILIZED,	10	3
63323-130-41	Doxy 100	10 mL in 1 VIAL	INJECTION, POWDER, LYOPHILIZED,	10	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63323-130	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	8	Current NDC, Legacy NDC, 2 package rows	20200610_b0894010-39bd-459f-8563-cf83343105ee.zip
63323-130	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	5	Current NDC, Legacy NDC, 2 package rows	20210312_b256babb-1bba-4b0c-8837-d13ba3af7659.zip
63323-130	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC ]	3	Current NDC, Legacy NDC, 2 package rows	20210204_a7b754e2-a028-469d-ba95-8412ef03ab0a.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
63323-130-02	EA - Each	63323-130	edc7cbba-452b-471d-8d2b-4a2a363804bd	1	2021-08-05
63323-130-03	EA - Each	63323-130	a20d17a4-29c2-4d0e-9ea1-581bd979c321	1	2021-09-07
63323-130-11	EA - Each	63323-130	48113d52-439a-4a9f-b934-26c54770a14a	1	2013-02-13
63323-130-13	EA - Each	63323-130	7698ad16-4f9a-4a8a-a05b-b70c7a026c53	1	2013-09-04
63323-130-17	EA - Each	63323-130	9f82722c-19ff-46b8-9323-dabe43b13861	1	2014-12-01
63323-130-41	EA - Each	63323-130	8403a847-92ed-40b5-ad20-d703f943c9e2	1	2022-01-06

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DOXYCYCLINE HYCLATE	ACTIVE INGREDIENT	19XTS3T51U	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	4
DOXYCYCLINE HYCLATE	ACTIVE INGREDIENT	19XTS3T51U	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	2
Doxycycline Hyclate	ACTIVE INGREDIENT	19XTS3T51U	DOXY 100 (DOXYCYCLINE HYCLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	1
DOXYCYCLINE HYCLATE	ACTIVE INGREDIENT	19XTS3T51U	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1
Doxycycline Anhydrous	ACTIVE MOIETY	334895S862	DOXY 100 (DOXYCYCLINE HYCLATE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GENERAL INJECTABLES & VACCINES, INC]	1
DOXYCYCLINE ANHYDROUS	ACTIVE MOIETY	334895S862	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	DOXY 100 (DOXYCYCLINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 20 · 391 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxycycline Hyclate	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	051654c7-8ba6-44f2-842c-72f515e9b32d	2026-09-15	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
doxycycline hyclate	DOXYCYCLINE HYCLATE	HAWAII REPACK, INC	88c429a1-351d-432e-b69b-d7a0afca482a	2026-09-09	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline Hyclate	DOXYCYCLINE HYCLATE	A-S Medication Solutions	9ecadbc8-3087-4692-916a-b7f392d8e8da	2026-09-09	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	5fdc01c3-c62f-40cf-8351-91cbcc43d379	2026-09-01	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline hyclate	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	df44c686-de34-487a-8741-a0a12993cab2	2026-08-27	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	2c29f716-bdb0-437d-92a4-d856b87db976	2026-08-26	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
DOXYCYCLINE HYCLATE	DOXYCYCLINE HYCLATE	NuCare Pharmaceuticals,Inc.	0106a3d3-db4d-f6ee-e063-6294a90a25e9	2026-08-26	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Electrolyte Plus	KALI MURIATICUM, L-ARGININE, L-CARNITINE, L-LEUCINE, L-ORNITHINE, L-VALINE, MAGNESIA MURIATICA, ASCORBICUM ACIDUM, BORAX, CHROMIUM OXYDATUM, FERRUM MURIATICUM, KALI CARBONICUM, MAGNESIUM GLUCONICUM DIHYDRICUM, NATRUM MURIATICUM, ZINCUM GLUCONICUM, CUPRUM METALLICUM, KALI PHOSPHORICUM, NICCOLUM METALLICUM, SELENIUM METALLICUM, VANADIUM METALLICUM, CALCAREA CARBONICA, CALCAREA PHOSPHORICA, MANGANUM CARBONICUM	Deseret Biologicals, Inc.	e3564733-8b88-4753-9077-9d74004d8ec9	2026-08-25	Warnings	Exact identifier unii: PQ6CK8PD0R
Mirexa Mini	MIREXA MINI	Oncora Pharma, LLC	ea48f64a-9a70-40df-ba25-098353273089	2026-08-25	Warnings, Adverse reactions	Exact identifier unii: PQ6CK8PD0R
Ascorbic Acid	ASCORBIC ACID	Renova Pharmaceuticals LLC	a6481bae-2397-44c7-a51d-4f47ad91bd2c	2026-08-19	Warnings, Adverse reactions	Exact identifier unii: PQ6CK8PD0R
Doxycycline	DOXYCYCLINE HYCLATE	Acella Pharmaceuticals, LLC	3fb9f5ad-90a2-4858-bc34-f800d8b2fa90	2026-08-18	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
M-Natal Plus	VITAMIN A, VITAMIN C, VITAMIN D, VITAMIN E, THIAMINE, RIBOFLAVIN, NIACIN, VITAMIN B6, FOLIC ACID, VITAMIN B12, CALCIUM, IRON, ZINC, COPPER	REMEDYREPACK INC.	5d67a268-437b-403d-9d05-6524c4a7c499	2026-08-11	Warnings	Exact identifier unii: PQ6CK8PD0R
doxycycline	DOXYCYCLINE	REMEDYREPACK INC.	f0fbf63a-e75c-40cf-b2e9-429deaac899d	2026-08-10	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline	DOXYCYCLINE	Avenacy Inc.	429813b4-0223-4d85-a844-b1227ff63b1e	2026-08-06	Warnings, Adverse reactions	Exact identifier rxcui: 310027 unii: 19XTS3T51U
PNV Prenatol	MULTIVITAMIN	PureTek Corporation	583f0194-0306-f31b-e063-6394a90a2a10	2026-08-06	Warnings, Adverse reactions	Exact identifier unii: PQ6CK8PD0R
Doxycycline Hyclate	DOXYCYCLINE HYCLATE	Major Pharmaceuticals	e7c14a8e-c713-4f03-94e8-1ec9ae077d4d	2026-08-05	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline Hyclate	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	2305ab4a-7d08-41f6-9c39-c9b6835be389	2026-08-05	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
doxycycline	DOXYCYCLINE	A-S Medication Solutions	fe8cd3c6-36d6-4d92-bc5c-833cd6f9cb32	2026-08-04	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
Doxycycline	DOXYCYCLINE HYCLATE	REMEDYREPACK INC.	db53637e-16ac-41b0-b9d5-553471405d64	2026-08-03	Warnings, Adverse reactions	Exact identifier unii: 19XTS3T51U
DOXYCYCLINE	DOXYCYCLINE	Lupin Pharmaceuticals, Inc.	2946fc05-78e5-4669-85d1-3a3979eceae0	2026-08-03	Warnings, Adverse reactions	Exact identifier rxcui: 310027 unii: 19XTS3T51U

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.